Betty Allen Gynecologic Cancer Foundation
Your Survival is Our Mission
DENVER (CBSMiami) – Nearly 14,000 women will die from ovarian cancer in 2019. Now, new research has found that women who use IUDs for birth control may be lowering their ovarian cancer risk. For five years, Amy Dickson Plache has bravely battled ovarian cancer with chemotherapy, clinical trials, ... Read More »
SOURCE: CBS Miami
Every 5 minutes a woman in the United States is diagnosed with a gynecologic cancer. The Betty Allen Gynecologic Cancer Foundation is offering FREE Know the 5 and Survive educational workshops to residential communities, colleges, businesses, religious organizations and women's groups. During our ... Read More »
By Denise Heady, University of California, Los Angeles Out of the 22,240 women in the United States who are diagnosed with ovarian cancer every year, only about 47 percent survive longer than five years. But Dr. Beth Karlan, the newly appointed director of cancer population genetics at UCLA's ... Read More »
SOURCE: Medical Express
By Katie O'Malley A “game-changing” drug for women living with ovarian cancer has received approval as a first stage treatment on the NHS. The drug, named Lynparza (olaparib), is being made available through the Cancer Drugs Fund to help women with a genetic form of the cancer. The ... Read More »
SOURCE: Independent.co.uk
By Anna Smith AstraZeneca and MSD have announced that Lynparza (olaparib) is now recommended for use within the Cancer Drugs Fund for women with newly diagnosed advancedBRCA-mutated ovarian cancer. The national Institute for Health and Care Excellence (NICE) recommended the drug specifically ... Read More »
SOURCE: PharmaTimes Online
April 9, 2019, by NCI Staff Tests for inherited genetic mutations can provide women diagnosed with ovarian or breast cancer with important information that can have implications for family members and potentially guide treatment decisions and longer-term screening for second cancers. However, ... Read More »
SOURCE: National Cancer Institute
October 11, 2018, by NCI Staff A new test can help to improve the clinical management of women who screen positive for human papillomavirus (HPV) infection in routine cervical cancer screening, an NCI-led study has shown. The test, called p16/Ki-67 dual stain, more accurately predicted whether ... Read More »
SOURCE: National Cancer Institute
May 2, 2018, by NCI Staff Researchers have shown that an experimental screening test can detect some endometrial and ovarian cancers at their early, more treatable stages. The test, called PapSEEK, is a type of liquid biopsy that identifies cancer-related alterations in DNA obtained from ... Read More »
SOURCE: National Cancer Institute
NCI Press Release —New findings from a study by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, show that U.S. incidence rates for aggressive subtypes of uterine cancer rose rapidly among women ages 30 to 79 from 2000 to 2015. The findings also reveal ... Read More »
SOURCE: National Cancer Institute
HOUSTON, Texas (KTRK) -- Kaylee Tolleson is officially cancer-free! The 9-year-old was surrounded by her family and the hospital staff as she ran across the halls and rang the bell in celebration. Earlier this year, Kaylee captured the hearts of many people, including Chief Meteorologist ... Read More »
SOURCE: ABC Eye Witness News
Mailing Address:
13300-56 S. Cleveland Ave.
Ft. Myers, FL 33907
Phone: (239) 935 – 8325
Email: info@gyncancerfl.org
